STOCK TITAN
  1. Home
  2. News
  3. EVFM

Evofem Biosciences Inc - EVFM STOCK NEWS

IMPACT
SENTIMENT
EVFM : OTC
Evofem to Participate in the Virtual Investor Ask the CEO Conference
conferences
IMPACT
SENTIMENT
EVFM : OTC
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire
fda approval
IMPACT
SENTIMENT
EVFM : OTC
Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor
IMPACT
SENTIMENT
EVFM : Nasdaq EVFMD : OTC EVFM : OTC
Evofem Biosciences Announces 1-for-125 Reverse Stock Split
IMPACT
SENTIMENT
EVFM : OTC EVFM : Nasdaq
Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update
earnings
IMPACT
SENTIMENT
EVFM : OTC EVFM : OTC EVFM : Nasdaq
Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary
management
IMPACT
SENTIMENT
EVFM : OTC EVFM : Nasdaq
Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required
IMPACT
SENTIMENT
EVFM : OTC EVFM : Nasdaq
Evofem Biosciences Announces Cost Reduction Measures
IMPACT
SENTIMENT
EVFM : OTC EVFM : Nasdaq
Evofem Biosciences Appoints Interim Chief Financial Officer
management
IMPACT
SENTIMENT
EVFM : OTC EVFM : Nasdaq
Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering
Stock EVFM logo
Evofem Biosciences Inc
OTC:EVFM

EVFM Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link

About EVFM

evofem is a biotechnology company focusing on developing innovative reproductive health products for women in every global market. evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. women need access to effective products that are well suited to their lifestyle and consistent with their core values. products include: amphora™ - a non-hormonal vaginal gel being investigated for contraceptive and microbicidal properties.